Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
5 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to SciSparc Ltd.’s names, not what it holds today.
Patents granted
5
5 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
19
since 2001, to Dec 31, 2025
Names they are printed under
4
a former name, its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
THERAPIX BIOSCIENCES LTD. a former name
IL, as the owner printed on each patent
7 publishedSciSparc Ltd. its own name
IL, as the owner printed on each patent. 4 more under the same name are not counted (printed in NI)
3 publishedTHERAPIX BIOSCIENCES LTD. a former name
named as the applicant on its applications, in IL
5 publishedSciSparc Ltd. its own name
named as the applicant on its applications, in IL
4 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Nov 8, 2022 | 11,491,172 | Compositions and methods of potentiating antimicrobials | Pharmaceuticals | SciSparc Ltd. |
| Feb 1, 2022 | 11,234,956 | Combination of cannabinoids and n-acylethanolamines | Pharmaceuticals | SciSparc Ltd. |
| Dec 28, 2021 | 11,207,290 | Combinations of cannabinoids and N-acylethanolamines | Pharmaceuticals | SciSparc Ltd. |
| Dec 14, 2021 | 11,197,845 | Combinations of cannabinoids and N-acylethanolamines | Pharmaceuticals | SciSparc Ltd. |
| Jun 19, 2018 | 10,000,567 | Humanized antibodies to cluster of differentiation 3 (CD3) | Biotechnology | THERAPIX BIOSCIENCES LTD. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Sep 28, 2023 | 2023/0302025 | METHODS FOR MAINTAINING MICROVASCULAR INTEGRITY | Pharmaceuticals | SciSparc Ltd. |
| Feb 9, 2023 | 2023/0045747 | COMPOSITIONS AND METHODS OF POTENTIATING ANTIMICROBIALS | Pharmaceuticals | SciSparc Ltd. |
| Jul 7, 2022 | 2022/0211647 | COMPOSITIONS AND METHODS FOR POTENTIATING DERIVATIVES OF 4-AMINOPHENOLS | Pharmaceuticals | SciSparc Ltd. |
| Mar 10, 2022 | 2022/0071949 | COMBINATIONS OF CANNABINOIDS AND N-ACYLETHANOLAMINES | Pharmaceuticals | SciSparc Ltd. |
| Mar 10, 2022 | 2022/0071948 | COMBINATIONS OF CANNABINOIDS AND N-ACYLETHANOLAMINES | Pharmaceuticals | SciSparc Ltd. |
| Jan 6, 2022 | 2022/0000833 | COMPOSITIONS AND METHODS FOR TREATING OBSTRUCTIVE SLEEP APNEA | Pharmaceuticals | THERAPIX BIOSCIENCES LTD. |
| Dec 23, 2021 | 2021/0393577 | COMBINATIONS OF CANNABINOIDS AND N-ACYLETHANOLAMINES | Pharmaceuticals | SciSparc Ltd. |
| Jun 17, 2021 | 2021/0177779 | COMBINATIONS OF OPIOIDS AND N-ACYLETHANOLAMINES | Pharmaceuticals | SciSparc Ltd. |
| Apr 1, 2021 | 2021/0093652 | COMPOSITIONS AND METHODS OF POTENTIATING ANTIMICROBIALS | Pharmaceuticals | THERAPIX BIOSCIENCES LTD. · patent 11,491,172 granted from it |
| Feb 6, 2020 | 2020/0038367 | COMBINATIONS OF CANNABINOIDS AND N-ACYLETHANOLAMINES | Pharmaceuticals | THERAPIX BIOSCIENCES LTD. · patent 11,197,845 granted from it |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.